Search Results 81 – 100 of 238
Date:
Source: Imaging Technique Illuminates Immune Status of Monkeys with HIV-Like Virus
Date:
Source: HIV Vaccine Elicits Antibodies in Animals that Neutralize Dozens of HIV Strains
Date:
Source: Recommendations Regarding the Use of Dolutegravir in Adults and Adolescents with HIV who are Pregnant or of Child-Bearing Potential
Date:
Source: Statement on Potential Safety Signal in Infants Born to Women Taking Dolutegravir
Date:
Source: FDA Drug Safety Communication: FDA to Evaluate Potential Risk of Neural Tube Birth Defects with HIV Medicine Dolutegravir
Date:
Source: Clinical Trial to Track Outcomes of Kidney Transplantation from HIV+ Donors to HIV+ Recipients
Date:
Source: Anti-HIV Drug Combination Does Not Increase Preterm Birth Risk
Date:
Source: Genetically Altered Broadly Neutralizing Antibodies Protect Monkeys From HIV-Like Virus
Date:
Source: Adult ARV Panel Classifies BIC/TAF/FTC as Recommended Initial Regimen for HIV
Date:
Source: One-Month Tuberculosis Prophylaxis as Effective as Nine-Month Regimen for People Living with HIV
Date:
Source: PrEP Not Reaching Most Americans Who Could Benefit
Date:
Source: High Uptake and Use of Vaginal Ring for HIV Prevention Observed in Open-Label Study
Date:
Source: Broadly Neutralizing Antibody Treatment May Target Viral Reservoir in Monkeys
Date:
Source: Risk of Acquiring HIV Increases During and After Pregnancy, Research Suggests
Date:
Source: Slight Changes to Broadly Neutralizing HIV Antibody Yield Great Dividends
Date:
Source: PHAT Life: Effective HIV Intervention for Youth in the Criminal Justice System
Date:
Source: Study Links Gut-Homing Protein Levels with HIV Infection Risk, Disease Progression
Date:
Source: Ped ARV Guideline Panel Accepting Scientific/Clinical Member Nominations
Date:
Source: NIH Begins Large HIV Treatment Study in Pregnant Women
Date:
Source: 15 Years Later, PEPFAR Continues to Save Lives